Skip to main content

JANE STREET GROUP, LLC

Position in GMAB — Genmab A/S

CIK 1595888 NEW YORK, NY

Position in GMAB

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$2,640,930
+$2,640,930 QoQ
Shares Held
98,432
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
16 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Derivatives in GMAB

reported options exposure · as of Mar 31, 2026
CallValue
$2,819,833
CallShares
105,100
PutValue
$289,764
PutShares
10,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,255,284,514 across 317 Biotechnology names. GMAB ranks #69 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GMAB

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,819,833 105,100
2026-03-31 $2,640,930 98,432
2026-03-31 $289,764 10,800
2025-12-31 $1,213,520 39,400
2025-12-31 $486,640 15,800
2025-09-30 $506,055 16,500
2025-06-30 $233,458 11,300
2025-06-30 $7,447,701 360,489
2025-03-31 $879,142 44,900
2025-03-31 $2,757,529 140,834
2024-12-31 $5,497,220 263,403
2024-06-30 $361,066 14,368
2023-09-30 $657,820 18,651
2023-06-30 $7,264,205 191,113
2023-03-31 $7,731,208 204,746
2022-12-31 $592,769 13,987
2022-09-30 $597,746 18,604
2021-12-31 $3,023,333 76,424
2021-09-30 $3,946,110 90,300
2021-09-30 $4,177,982 95,606
2021-03-31 $1,827,711 55,672
2020-09-30 $421,015 11,500
2020-09-30 $235,328 6,428